Sanders Corazon (Corsee) D. sold 27,370 shares of Legend Biotech Corp at $9.46 for −$259k on Sep 29, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Oct 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$258,920.20Shares × reported price
Shares traded
27,370Ordinary Shares
Price per share
$9.46Reported price. Read footnotes for ranges.
% of reported position traded
34.17%This security and ownership context
Holdings after
52,731Direct
Trade date
Sep 29, 2026Sell
Filed
Oct 1, 2026, 4:04 PM ET2-day reporting delay
Accession
0001796536-26-000010Code S · Transaction 232754
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 80,101 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

LEGN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LEGN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +2.9%1w ago −3.5%1d ago −3.6%
Returns since7d −3.2%30d +12%90d180d1y

Footnotes in full

F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. F2: The price reported in Column 4 is a weighted average price. The prices sold ranged from $9.445 to $9.48 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.